To the full analysis
Humana stock: growth
HUMHumana reported $129.66B in revenue for fiscal 2025, up 10.1% on the prior year, up 10.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.9%
per year from 2006 to 2025, per share 11.7%
Earnings (Annual rate)
4.8%
per year from 2006 to 2025, per share 6.5%
Free cash flow (Annual rate)
−7%
per year from 2006 to 2025, per share −5.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 10.9% | 9.1% | 9.9% |
| Revenue per share | 13.0% | 11.5% | 11.7% |
| Earnings | −18.8% | −0.7% | 4.8% |
| Earnings per share | −17.3% | 1.5% | 6.5% |
| Free cash flow | −39.6% | 0.8% | −7.0% |
| Free cash flow per share | −38.5% | 3.0% | −5.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $21.42B | $487.42M | $1.49B |
| 2007 | $25.29B | $833.68M | $985.02M |
| 2008 | $29.05B | $647.15M | $720.74M |
| 2009 | $30.96B | $1.04B | $1.24B |
| 2010 | $33.87B | $1.1B | $2.02B |
| 2011 | $36.83B | $1.42B | $1.74B |
| 2012 | $39.13B | $1.22B | $1.51B |
| 2013 | $41.31B | $1.23B | $1.28B |
| 2014 | $48.5B | $1.15B | $1.09B |
| 2015 | $54.29B | $1.28B | $345M |
| 2016 | $54.41B | $614M | $1.41B |
| 2017 | $53.8B | $2.45B | $3.53B |
| 2018 | $56.94B | $1.68B | $1.56B |
| 2019 | $64.93B | $2.71B | $4.55B |
| 2020 | $77.19B | $3.37B | $4.68B |
| 2021 | $83.65B | $2.93B | $920M |
| 2022 | $92.92B | $2.81B | $3.45B |
| 2023 | $106.44B | $2.49B | $2.98B |
| 2024 | $117.81B | $1.21B | $2.39B |
| 2025 | $129.66B | $1.19B | $375M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.